Inhibrx Biosciences, Inc. INBX Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s deferred tax assets and other non-current assets?
- Inhibrx Biosciences, Inc. (INBX) reported deferred tax assets and other non-current assets of $4.38M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Inhibrx Biosciences, Inc.'s deferred tax assets and other non-current assets decreased by 35.6% year-over-year, from $6.8M to $4.38M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s deferred tax assets and other non-current assets?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s deferred tax assets and other non-current assets has grown at a 17.6% compound annual growth rate (CAGR), from $3.16M to $4.38M.